Evidence map›Paper›PMID 35107327›Full record

ArticleMicrobiology spectrum2022

Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Detection Tests Using Oral, Anterior Nasal, and Nasopharyngeal Swabs: a Diagnostic Accuracy Study.

Michael Wölfl-Duchek, Felix Bergmann, Anselm Jorda, Maria Weber, Matthias Müller, Tamara Seitz, Alexander Zoufaly, Robert Strassl, Markus Zeitlinger, Harald Herkner and 3 more

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 4 pooled it
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 4 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Michael Wölfl-DuchekDepartment of Clinical Pharmacology, Medical University of Viennagrid.22937.3d, Vienna, Austria.
Felix BergmannDepartment of Clinical Pharmacology, Medical University of Viennagrid.22937.3d, Vienna, Austria.
Anselm JordaDepartment of Clinical Pharmacology, Medical University of Viennagrid.22937.3d, Vienna, Austria.
Maria WeberDepartment of Clinical Pharmacology, Medical University of Viennagrid.22937.3d, Vienna, Austria.
Matthias MüllerDepartment of Clinical Pharmacology, Medical University of Viennagrid.22937.3d, Vienna, Austria.
Tamara SeitzFourth Medical Department for Infectious Diseases and Tropical Medicine, Clinic Favoriten, Vienna, Austria.
Alexander ZoufalyFourth Medical Department for Infectious Diseases and Tropical Medicine, Clinic Favoriten, Vienna, Austria.
Robert StrasslDepartment of Laboratory Medicine, Division of Clinical Virology, Medical University of Viennagrid.22937.3d, Vienna, Austria.
Markus ZeitlingerDepartment of Clinical Pharmacology, Medical University of Viennagrid.22937.3d, Vienna, Austria.ORCID 0000-0002-1873-3953
Harald HerknerDepartment of Emergency Medicine, Medical University of Viennagrid.22937.3d, Vienna, Austria.
Harald SchnidarScarletred Holding GmbH, Vienna, Austria.
Karolina AnderleDepartment of Clinical Pharmacology, Medical University of Viennagrid.22937.3d, Vienna, Austria.
Ulla DerhaschnigDepartment of Clinical Pharmacology, Medical University of Viennagrid.22937.3d, Vienna, Austria.
Medical University of Vienna · ATSigmund Freud Privatuniversität Wien · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of our study was to evaluate the sensitivity and specificity of rapid antigen detection tests versus those of reverse transcriptase PCR (RT-PCR) using oral, anterior nasal, and nasopharyngeal swabs. The underlying prospective, diagnostic case-control-type accuracy study included 87 hospitalized and nonhospitalized participants in a positive and a negative sample cohort between 16 March and 14 May 2021 in two hospitals in Vienna. SARS-CoV-2 infection status was confirmed by RT-PCR. Participants self-performed one oral and one anterior nasal swab for the rapid antigen test, immediately followed by two nasopharyngeal swabs for the rapid antigen test and RT-PCR by the investigator. Test results were read after 15 min, and participants completed a questionnaire in the meantime. Test parameters were calculated based on the evaluation of 87 participants. The overall sensitivity of rapid antigen detection tests versus that of RT-PCR with oral, anterior nasal, and nasopharyngeal samples was 18.18% (95% confidence interval [CI] 8.19% to 32.71%), 63.04% (95% CI 47.55% to 76.79%), and 73.33% (95% CI 58.06% to 85.4%), respectively. All sampling methods had a test specificity of 100% regardless of the cycle threshold (

Indexed as

AdultAgedAged, 80 and overAntigens, ViralCOVID-19COVID-19 Nucleic Acid TestingCOVID-19 Serological TestingFemaleHumansMaleMiddle AgedMouthNasopharynxNosePolymerase Chain ReactionProspective StudiesAntigens, Viralinfectious diseasePCRrapid antigen detectionSARS-CoV-2sensitivityspecificityswabbingtest performance

Identifiers

PMID35107327
PMCPMC8809344
OpenAlexW4210747103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.